## Distinguishing Direct vs Indirect Pathways ### Anatomical Definition The **direct and indirect pathways** are the two main output circuits from striatum, differentiated primarily by: 1. **Dopamine receptor expression on medium spiny neurons (MSNs)** 2. **Target nuclei and projection pattern** 3. **Functional consequence on thalamic output** ### Comparison Table | Feature | Direct Pathway | Indirect Pathway | | --- | --- | --- | | **MSN receptor type** | D1 dopamine receptors | D2 dopamine receptors | | **Primary projection** | Striatum → GPi/SNr (direct) | Striatum → GPe → STN → GPi/SNr | | **Neurotransmitter at MSN** | GABA (inhibitory) | GABA (inhibitory) | | **Net effect on GPi/SNr** | Disinhibition (reduces tonic inhibition) | Increased inhibition | | **Thalamic output** | Increased (movement facilitation) | Decreased (movement inhibition) | | **Dopamine effect** | Enhances pathway (D1 agonism) | Suppresses pathway (D2 antagonism) | **Key Point:** The **D1 vs D2 receptor expression** on striatal MSNs is the fundamental anatomical discriminator. D1-expressing neurons form the direct pathway; D2-expressing neurons form the indirect pathway. This is the most specific and testable distinction. ### Functional Context **High-Yield:** In Parkinson's disease, loss of dopamine preferentially affects the indirect pathway (via loss of D2 antagonism), leading to excessive GPi inhibition of thalamus → hypokinesia. In Huntington's disease, loss of indirect pathway MSNs → unopposed direct pathway → hyperkinesia. ### Why This is the Best Answer Option 0 directly names the **receptor phenotype and anatomical target**, which is the gold-standard neuroanatomical distinction taught in all textbooks. It is objective, measurable, and forms the basis for understanding all downstream functional differences. 
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.